MOTS-c Research: What Published Studies Have Investigated

What is MOTS-c?

What is MOTS-c? It is a 16-amino-acid mitochondrial-derived peptide (MDP) encoded by a short open reading frame within the mitochondrial 12S rRNA (MT-RNR1) region — the source of the name, “Mitochondrial ORF of the Twelve-S rRNA type-c.” It was first described by Lee et al. in Cell Metabolism (2015) and is one of a small family of mitochondrial-derived peptides that also includes humanin and the SHLPs. That the coding sequence sits inside mitochondrial DNA rather than the nuclear genome is the feature that makes it unusual as a research target.

Molecule properties

MOTS-c is a short peptide of 16 residues, mitochondrially encoded in origin, and supplied for research as a lyophilized powder. A distinction worth holding is that between the endogenous peptide, expressed within cells, and the synthetic research-grade material catalogued for laboratory study — the two share a sequence but are described in different contexts. These are molecule facts only; no handling-for-use or reconstitution instruction is given here.

Mechanisms researchers have examined

MOTS-c is described as a pleiotropic signalling peptide whose mechanisms were characterised primarily in cell and animal models. The MOTS-c mechanism directions researchers have examined include:

• AMPK activation via the folate cycle — Lee et al. (2015) reported that MOTS-c targets the folate–methionine one-carbon cycle, leading to accumulation of AICAR, an endogenous AMPK activator — an indirect route distinct from the canonical AMP/ATP mechanism.
• Mitochondrial-to-nuclear retrograde signalling — Kim et al. (2018; PMID 29983246) reported that MOTS-c translocates to the nucleus under metabolic stress and associates with antioxidant-response-element (ARE) regulation and NRF2-related transcription factors.
• Skeletal-muscle metabolic signalling — glucose-handling and fatty-acid-oxidation pathways were examined in myoblast and muscle models.
• Exercise-associated expression — Reynolds et al. (2021) reported that exercise induces endogenous MOTS-c in muscle and circulation.

Each bullet names a mechanism studied in a model, not an effect in a reader. The literature frames MOTS-c as a pleiotropic signalling peptide characterised chiefly in cell and animal systems.

Research models in the literature

The reported models are preclinical: cultured myoblasts and cells; rodent models of diet-induced metabolic dysfunction — Lee et al. (2015) examined high-fat-diet and age-related insulin-resistance models in mice; and aging and physical-capacity models — Reynolds et al. (2021, Nature Communications) examined running capacity and muscle homeostasis across young, middle-aged and old mice. On the human side, Fuku et al. (2015, Aging Cell) described the m.1382A>C mitochondrial-DNA variant in the MOTS-c region and a hypothesised population-genetics association, though later work questioned the longevity link. Stated plainly: there is little to no interventional human data — the body of evidence is preclinical, and the exercise-associated finding is a research observation in mice, not a claim about people.

A 2023 review that collects this literature (PMC9854231) groups the reported mechanisms under the headings of stress, metabolism and aging, and it reiterates the same limitation: the characterisation rests almost entirely on cell-culture and rodent systems. Where human observations exist, they are expression measurements or genetic-association data — describing where the peptide appears and how a sequence variant tracks in a population, rather than any outcome produced in a person. Readers approaching this material should keep that preclinical boundary in view when interpreting any single study.

MOTS-c among the mitochondrial-derived peptides

Among mitochondrial-derived peptides, MOTS-c is usually discussed alongside humanin and the SHLPs — a family context rather than a comparison of results. What distinguishes MOTS-c as a research target is its encoding region and the specific mechanisms studied above. Humanin — the first-described mitochondrial-derived peptide — and the SHLPs (small humanin-like peptides) are read from neighbouring stretches of mitochondrial rRNA, whereas MOTS-c is read from the 12S (MT-RNR1) region and is set apart in the literature by the folate-cycle/AMPK route reported for it rather than the receptor-interaction work more often associated with humanin. For a related tissue-and-recovery research explainer, see BPC-157 research. This is research-focus positioning only, not stacking or use advice.

Research-grade sourcing & verification

For laboratory research use only, MOTS-c is supplied with a per-batch Certificate of Analysis reporting HPLC purity (%) and mass-spec identity confirmation, with lot-level verification. Check the exact batch on the self-serve verify tool, and see how to read a COA for what the certificate reports. Framing is quality and identity assurance for research — not outcomes.

Frequently asked questions

Literature cited

1. Lee C, Zeng J, Cohen P, et al. “The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance.” Cell Metabolism. 2015.
2. Kim KH, Son JM, Benayoun BA, Lee C. “The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress.” Cell Metabolism. 2018 (PMID 29983246).
3. Reynolds JC, et al. “MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis.” Nature Communications. 2021;12:470.
4. Fuku N, et al. “The mitochondrial-derived peptide MOTS-c: a player in exceptional longevity?” Aging Cell. 2015 (m.1382A>C variant; later work questioned the association).
5. Review context: “Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging.” 2023 (PMC9854231).